OC
INVA icon

Oppenheimer & Co’s Innoviva INVA Stock Holding History

Oppenheimer & Co’s Portfolio INVA Stock Details INVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$514K Buy
22,616
+247
+1% +$5.65K 0.01% 1246
2026
Q1 		$521K Buy
+22,369
New +$482K 0.01% 1175
2015
Q1 		– Sell
-10,993
Closed -$156K – 1511
2014
Q4 		$156K Buy
10,993
+300
+3% +$4.51K ﹤0.01% 1275
2014
Q3 		$183K Buy
10,693
+3,800
+55% +$87.3K 0.01% 1269
2014
Q2 		$205K Sell
6,893
-6,242
-48% -$150K 0.01% 1245
2014
Q1 		$328K Sell
13,135
-372
-3% -$10.9K 0.01% 1003
2013
Q4 		$388K Hold
13,507
– – 0.01% 919
2013
Q3 		$445K Sell
13,507
-42,939
-76% -$1.34M 0.02% 791
2013
Q2 		$1.75M Buy
+56,446
New +$1.51M 0.07% 337

Other funds holding INVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Oppenheimer & Co's INVA Position: Q2 2026 in Review

Oppenheimer & Co increased its Innoviva (INVA) stake by 1.1% in Q2 2026, buying an estimated $5.65K and bringing the position to 22,616 shares worth $514K. The position accounts for 0.01% of the portfolio, ranked #1246.

Oppenheimer & Co first reported a position in INVA in Q2 2013 and has held it in 9 quarters since. The position peaked at $1.75M in Q2 2013. 308 funds tracked by Wall St. Rank hold INVA as of Q2 2026.

  • Oppenheimer & Co held 22,616 shares of Innoviva worth $514K as of Q2 2026.
  • Oppenheimer & Co bought 247 Innoviva shares in Q2 2026, an estimated $5.65K.
  • Innoviva made up 0.01% of Oppenheimer & Co's portfolio in Q2 2026, its #1246 holding.
  • Oppenheimer & Co first reported a position in Innoviva in Q2 2013 and has held it in 9 quarters since.
  • Oppenheimer & Co's Innoviva position peaked at $1.75M in Q2 2013.
  • 308 funds tracked by Wall St. Rank held Innoviva as of Q2 2026.

Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.